Vivatides Therapeutics Raises $54M Series A Round Led by Qiming Venture Partners
Vivatides Therapeutics Raises $54M Series A Funding Date: April 10, 2026 Company: Vivatides Therapeutics Funding Type: Venture Capital (VC) Funding Stage: Series A Funding Amount Raised: $54M Lead Investors: Qiming Venture Partners Participants: Apricot Capital, … Read more